Di acetyl nadolol and tri acetyl nadolol potential pro drugs of nadolol with ocular beta blocking activity
Bergamini, M.V.W.; Anderson, J.; Rajadhyaksha, V.J.; Schoenwald, R.; Krause, P.
IOVS Investigative Ophthalmology and Visual Science 22(3): 230
1982
ISSN/ISBN: 0146-0404 Accession: 028084823
PDF emailed within 1 workday: $29.90
Related References
Yamaguchi, T.; Oida, T.; Ikeda, C.; Sekine, Y. 1986: Intestinal absorption of a beta-adrenergic blocking agent nadolol. III. Nuclear magnetic resonance spectroscopic study on nadolol-sodium cholate micellar complex and intestinal absorption of nadolol derivatives in rats Chemical and Pharmaceutical Bulletin 34(10): 4259-4264Yamaguchi, T.; Ikeda, C.; Sekine, Y. 1986: Intestinal absorption of a beta-adrenergic blocking agent nadolol. I. Comparison of absorption behavior of nadolol with those of other beta-blocking agents in rats Chemical and Pharmaceutical Bulletin 34(8): 3362-3369
Yamaguchi, T.; Ikeda, C.; Sekine, Y. 1987: Intestinal absorption of a beta adrenergic blocking agent nadolol enhancement of in situ and in vivo absorption of nadolol in rats International Journal of Pharmaceutics 37(1-2): 127-134
Yamaguchi, T.; Ikeda, C.; Sekine, Y. 1986: Intestinal absorption of a beta-adrenergic blocking agents nadolol. II. Mechanism of the inhibitory effect on the intestinal absorption of nadolol by sodium cholate in rats Chemical and Pharmaceutical Bulletin 34(9): 3836-3843
Yamaguchi, T; Ikeda, C; Sekine, Y 1987: Intestinal absorption of a -adrenergic blocking agent nadolol. Enhancement of in situ and in vivo absorption of nadolol in rats International Journal of Pharmaceutics 37(1-2): 127-134
Duzman, E.; Chen, C.C.; Anderson, J.; Blumenthal, M.; Twizer, H. 1982: Diacetyl derivative of nadolol. I. Ocular pharmacology and short-term ocular hypotensive effect in glaucomatous eyes Archives of Ophthalmology 100(12): 1916-1919
Kravetz, D.; Romero, G.; Bildozola, M.; Abecasis, R.; Argonz, J.; Gonzalez, B.; Calcagno, J.; Terg, R. 1996: Nadolol plus spironolactone is not more effective than nadolol alone in decreasing portal pressure in cirrhotic patients Hepatology 24(4 Part 2): 206A
Lo, G-Ho.; Chen, W-Chi.; Wang, H-Min.; Lee, C-Chang. 2010: Controlled trial of ligation plus nadolol versus nadolol alone for the prevention of first variceal bleeding Hepatology 52(1): 230-237
Deplano, A.; Careddu, G.; Reho, A.; Fancello, A.; Garrucciu, G.; Manzoni, N.E.; Tocco, A.; Solinas, A. 2001: The long-term variceal pressure response to nadolol alone vs nadolol plus isosorbide mononitrate Journal of Hepatology 34(Suppl 1): 53
Signorelli, S.; Negrini, F.; Paris, B.; Bonelli, M.; Girola, M. 1996: Prevention of re-bleeding from varices Trial of nadolol compared to nadolol plus sclerotherapy Journal of Hepatology 25(Suppl 1): 92
Cherchi, A.; Sau, F.; Mercuro, G.; Seguro, C.; Lai, O. 1985: Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo La Clinica Terapeutica 113(4): 301-306
Merkel, C.; Gatta, A.; Marin, R.; Donada, C.; Cavallarin, G.; Torboli, P.; Amodio, P.; Susanna, S.; Mazzaro, C.; Enzo, E.; Beltrame, P.; Sebhastianelli, G.; Gtip, T. 1995: Nadolol vs nadolol plus isosorbide-5-mononitrate for primary prophylaxis of variceal bleeding A multicenter clinical trial Journal of Hepatology 23(Suppl 1): 69
Deplano, A.; Reho, A.; Garrucciu, G.; Multinu, C.; Scarpa, S.; Careddu, G.; Tocco, A.; Manzoni, N.; Solinas, A. 2001: The long-term variceal pressure response to nadolol and nadolol plus nitrates in patients with large varices Hepatology 34(4 Pt 2): 531A
Enzo, E.; Merkel, C.; Sacerdoti, D.; Bolognesi, M.; Marin, R.; Gatta, A. 1996: Haemodynamic evaluation of the addition of isosorbide-5-mononitrate to nadolol in cirrhotic patients with insufficient response to nadolol alone Italian Journal of Gastroenterology 28(5): 292-293
Frishman, W. 1980: Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 9. Nadolol: a new long-acting beta-adrenoceptor blocking drug American Heart Journal 99(1): 124-128
Merkel, C.; Gatta, A.; Amodio, P.; Sacerdoti, D.; Donada, C.; Donadon, V.; Cavallarin, G.; Casson, F.F.; Torboli, P. 1993: Nadolol of nadolol plus isosorbide-5-mononitrate in the prophylaxis of first variceal bleeding in patients with cirrhosis Interim analysis of a Multicenter Study Journal of Hepatology 18(Suppl 1): S147-S148
Merkel, C.; Gatta, A.; Donada, C.; Enzo, E.; Cavallarin, G.; Angeli, P.; Marin, R.; Amodio, P.; Donadon, V. 1994: Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis Journal of Hepatology 21(Suppl 1): S49
Merkel, C.; Gatta, A.; Susanna, S.; Mazzaro, C.; Beltrame, P.; Donada, C.; Enzo, E.; Marin, R.; Amodio, P.; Torboli, P.; Angeli, P.; Cavallarin, G.; Sebastianelli, G.; G T I P, G. T. I. P. 1995: Long-term effect of nadolol or nadolol plus isosorbide-5-mononitrate on renal function and ascites formation in patients with cirrhosis Hepatology (Baltimore, Md.) 22(3): 808-813
Linda, P.; D'amico, G.; Patti, R.; Politi, F.; Vizzini, G.; Traina, M.; Contino, A.; Caltagirone, M.; Madonia, S.; Pagliaro, L. 2001: Isosorbide mononitrate with nadolol compared to nadolol alone for prevention of recurrent bleeding in cirrhosis A double-blind placebo-controlled randomised Gastroenterology 120(5 Suppl 1): A 375
Pietrosi, G.; D'amico, G.; Pasta, L.; Patti, R.; Vizzini, G.; Traina, M.; Madonia, S.; Licata, A.; Pagliaro, L. 1999: Isosorbide mononitrate with nadolol compared to nadolol alone for prevention of first bleeding in cirrhosis A double-blind placebo-controlled randomised trial Journal of Hepatology 30(Suppl 1): 66